DUTBF — Duality Biotherapeutics Inc/ADR
—
OTC ·
Unknown ·
Unknown ·
CIK 2085208 ·
China
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 3,892,874,000 | 1,276,399,000 | 1,466,210,000 |
| Jun 2025 | — | — | — | — | 4,177,030,000 | 2,994,180,000 | 1,264,269,000 |
| Dec 2024 | 479,253,000 | 125,119,000 | -133,216,000 | -483,952,000 | 2,090,222,000 | 1,208,906,000 | 4,112,121,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$265,358,000
Investing CF
$-130,312,000
Financing CF
$-4,309,000
CapEx
$-10,060,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-08-25
Balance + Analyst (yfinance extras)
Retained Earnings
$-4,854,762,000
Inventory
—
Receivables
—
ST Investments
$2,097,561,000
EBIT TTM
$-478,586,000
Pretax Income TTM
$-478,647,000
Interest Exp TTM
$61,000
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,851,735,000 | -455,001,000 | -2,594,827,000 | 3,892,874,000 | 1,466,210,000 | 2,426,664,000 | 194,583,000 |
| Dec 2024 | 1,941,257,000 | -203,413,000 | -1,050,434,000 | 2,090,222,000 | 4,112,121,000 | -2,021,899,000 | 285,781,000 |
| Dec 2023 | 1,786,540,000 | 740,582,000 | -357,512,000 | 1,499,909,000 | 2,623,822,000 | -1,123,913,000 | 816,335,000 |
| Dec 2022 | 1,600,000 | -369,717,000 | -387,090,000 | 463,737,000 | 1,232,854,000 | -769,117,000 | -299,470,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BRRN | Bryn Inc. | $945.00B | $2100.00 | — |
| SPY | SPDR S&P 500 ETF TRUST | $707.93B | $771.35 | — |
| TMO | THERMO FISHER SCIENTIFIC INC. | $249.58B | $675.00 | — |
| KLAC | KLA CORP | $245.53B | $187.92 | — |
| IBM | INTERNATIONAL BUSINESS MACHINES CORP | $212.46B | $225.51 | — |
News headlines (Yahoo Finance, 1h cache)
Duality Biotherapeutics (SEHK:9606) Stock Trades At A Premium On Its 50% Slump
2026-09-06 17:05 · Yahoo
DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBio's DUPAC Novel-Payload Platform
2026-08-28 04:19 · Yahoo
DualityBio (9606.HK) Announces 2025 Annual Results
2026-03-24 07:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.